2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Updates on mCRC: FDA Approved Encorafenib + Cetuximab Combination w/ or w/o Binimetinib for BRAF V600E mCRC - Which Option Has Better Overall Efficacy? Is This the New SoC?

90 views
September 16, 2020
Comments 0
Login to view comments. Click here to Login